Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Opioid Use
  • Postoperative Pain
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: Patients in the interventional group will receive a total of 5 mL of local anesthetic bilaterally near their temples.Masking: Double (Participant, Care Provider)Masking Description: Both groups will receive a small circular band-aid on their temples.Primary Purpose: Treatment

Participation Requirements

Age
Younger than 618 years
Gender
Both males and females

Description

Patients between 6 months and 18 years undergoing T&A surgical procedures will be reviewed for potential study enrollment. If participants agree to participate, they will be randomized into either the suprazygomatic maxillary nerve (SZaMN) block treatment cohort or the control cohort i.e standard of...

Patients between 6 months and 18 years undergoing T&A surgical procedures will be reviewed for potential study enrollment. If participants agree to participate, they will be randomized into either the suprazygomatic maxillary nerve (SZaMN) block treatment cohort or the control cohort i.e standard of care. After anesthesia induction, patients randomized into the SZaMN- treatment group will receive a bilateral single injection SZaMN block under general anesthesia in the operating room. The injection will occur near the temples above the cheek bones. Participants enrolled into the control group will receive standard of care with no changes to their anesthetic or surgical care. Both groups will be asked for their verbal pain scores in the PACU and we will track their opioid consumption throughout the next few days after their procedure.

Tracking Information

NCT #
NCT04797559
Collaborators
Not Provided
Investigators
Study Director: Ban C Tsui, MD Professor Principal Investigator: Carole Lin, MD Pediatric Anesthesiologist